In one paragraphArticle in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Elena G Arias-SalgadoServicio de Hematología y Hemoterapia, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, 28046 Madrid, Spain.
María Teresa Álvarez RománServicio de Hematología y Hemoterapia, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, 28046 Madrid, Spain.ORCID 0000-0003-3296-4288 Abel Dos Santos OrtasServicio de Hematología y Hemoterapia, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, 28046 Madrid, Spain.ORCID 0000-0003-3182-9869 Ihosvany Fernandéz-BelloServicio de Hematología y Hemoterapia, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, 28046 Madrid, Spain.ORCID 0000-0001-7822-8900 Elena Monzón ManzanoServicio de Hematología y Hemoterapia, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, 28046 Madrid, Spain.ORCID 0000-0002-7967-6358 Paula AcuñaServicio de Hematología y Hemoterapia, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, 28046 Madrid, Spain.ORCID 0000-0002-0259-8056 Mónica Martín SalcesServicio de Hematología y Hemoterapia, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, 28046 Madrid, Spain.
Maria Isabel Rivas PollmarServicio de Hematología y Hemoterapia, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, 28046 Madrid, Spain.ORCID 0009-0007-6322-0659 Sara García BarcenillaServicio de Hematología y Hemoterapia, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, 28046 Madrid, Spain.ORCID 0000-0002-8706-0668 Nora V ButtaServicio de Hematología y Hemoterapia, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, 28046 Madrid, Spain.ORCID 0000-0003-4601-7150 Víctor Jimenéz-YusteServicio de Hematología y Hemoterapia, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, 28046 Madrid, Spain.
Funding
Cátedra UAM-Roche 063203CSL Behring PI-4751Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union PI19/00631 and PI22/01461Investigator-Initiated Research grant from Baxalta GmbH, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited no. IISR-2019-104361
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
bypassing agentsemicizumabglobal coagulation assayshemophiliainhibitorsrecombinant factor IXthrombin generation
Identifiers
PMID42072318
PMCPMC13113436
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390